Poster No:
1704
Submission Type:
Abstract Submission
Authors:
Jacob Bunyamin1, Thanomporn Wittayacharoenpong1, Mohammad-Reza Nazem-Zadeh1, Parveen Sagar1, Noam Bosak1, Zhibin Chen1, Joshua Laing1, Matthew Gutman1, Martin Hunn1, Patrick Kwan1, Terence O'Brien2, Meng Law2, Ben Sinclair2, Andrew Neal1
Institutions:
1Monash University, Melbourne, VIC, 2Monash University, Melbourne, Victoria
First Author:
Co-Author(s):
Meng Law
Monash University
Melbourne, Victoria
Introduction:
The success of epilepsy surgery relies on accurately identifying the epileptogenic zone (EZ). There is a lack of imaging biomarkers that correlate with epileptogenicity. We aim to explore whether gray matter volume (GMV) is associated with stereo-electroencephalography (SEEG) epileptogenicity biomarkers.
Methods:
We included 3T non-contrast T1 scans from MRI-positive and MRI-negative drug-resistant focal epilepsy patients admitted for SEEG and age-sex-matched non-epileptic controls. MRI end: We segmented and modulated the T1 scans (pre-SEEG for epilepsy patients) to obtain a GMV map for each subject using CAT12. We then performed a non-parametric voxel-based comparison on SnPM between each patient's scan and the controls, resulting in pseudo-t-maps reflecting GMV differences between patients and controls, adjusted for age, sex, and total intracranial volumes. SEEG end: We classified SEEG contacts based on their involvement in (i) the EZ and (ii) interictal epileptogenicity biomarkers. The EZ was defined as contacts proposed for primary EZ radio-frequency thermocoagulation (RF-THC) after the SEEG procedure. Interictal epileptogenicity biomarkers were defined as contacts generating the top 10% of spikes, fast ripples, and cross-rates of HFO*Spikes for each patient. Statistical analysis: We calculated the mean GMV value within a 3 mm radius at each SEEG contact coordinate from the pseudo-t-maps. We then performed mixed-effect logistic regression and performance analysis to assess the ability of GMV to classify epileptogenic vs non-epileptogenic contacts within this dataset.

·Figure 1. Study Methodology
Results:
We included 50 patients (mean age 33.7±10.1 years, female 52.0%, MRI-negative 76.0%) and 68 controls (mean age 34.90±9.86 years, female 55.9%). Epileptogenic zone: From 4,878 contacts, increased GMV was associated with contacts involved in the EZ across the whole cohort (OR=1.19, 95% CI: 1.10-1.29, p<0.001), MRI-positive (OR=1.24, 95% CI: 1.09-1.40, p<0.001), and MRI-negative subgroup (OR=1.16, 95% CI: 1.04-1.28, p=0.005). GMV had a fair discriminative ability in the whole cohort (AUC 0.72), and MRI-negative subgroup (AUC 0.72), but was poor for the MRI-positive subgroup (AUC 0.69). At their optimal cut-off point, the sensitivity and specificity of GMV were 64% and 68% (whole cohort), 55% and 76% (MRI-positive), and 74% and 60% (MRI-negative subgroup). Interictal epileptogenicity biomarkers: From 5,346 contacts, there was no association between GMV and contacts displaying the top 10% of spikes (p=0.527), fast ripples (p=0.827), and cross-rates of HFO*Spikes (p=0.911) in the whole cohort. GMV had a poor ability to discriminate contacts within the top 10% of spikes (AUC 0.50), fast ripples (AUC 0.51), and cross-rates of HFO*Spikes (AUC 0.52) in the whole cohort.
Conclusions:
In our cohort, increased local GMV can discriminate epileptogenic vs non-epileptogenic SEEG contacts with a fair ability. Further assessment with unseen datasets is required to assess the generalizability of its performance.
Disorders of the Nervous System:
Neurodevelopmental/ Early Life (eg. ADHD, autism)
Neuroanatomy, Physiology, Metabolism and Neurotransmission:
Anatomy and Functional Systems 1
Physiology, Metabolism and Neurotransmission:
Neurophysiology of Imaging Signals 2
Keywords:
ELECTROPHYSIOLOGY
Epilepsy
MRI
STRUCTURAL MRI
Other - Stereo-EEG
1|2Indicates the priority used for review
By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.
I accept
The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information.
Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:
I do not want to participate in the reproducibility challenge.
Please indicate below if your study was a "resting state" or "task-activation” study.
Other
Healthy subjects only or patients (note that patient studies may also involve healthy subjects):
Patients
Was this research conducted in the United States?
No
Were any human subjects research approved by the relevant Institutional Review Board or ethics panel?
NOTE: Any human subjects studies without IRB approval will be automatically rejected.
Yes
Were any animal research approved by the relevant IACUC or other animal research panel?
NOTE: Any animal studies without IACUC approval will be automatically rejected.
Not applicable
Please indicate which methods were used in your research:
EEG/ERP
Structural MRI
Other, Please specify
-
Stereo-EEG
For human MRI, what field strength scanner do you use?
3.0T
Which processing packages did you use for your study?
SPM
Provide references using APA citation style.
-
No